Cosmetic
Fractional laser resurfacing treats only a fraction of the skin surface at a time, stimulating collagen with less downtime than fully ablative CO2 laser.
Medically reviewed by Steven Leibowitz, MDOculoplastic SurgeonLast updated June 2026
Your Surgeon
Steven Leibowitz, MD
Cosmetic and Reconstructive Surgery of Eyelids, Orbits, and Tear Ducts
🏅 ASOPRS Fellow
Fractional laser resurfacing has become one of the most versatile tools in periocular skin rejuvenation, bridging the gap between the dramatic—but demanding—results of fully ablative laser and the gentle, incremental effect of topical treatments. Rather than removing the entire surface of the skin, a fractional laser treats only a fraction of the skin at any one time, leaving islands of untouched tissue between microscopic treatment zones. This architecture is the key to its appeal: it stimulates meaningful collagen remodeling while dramatically shortening the recovery period compared with traditional resurfacing.
For patients bothered by fine eyelid wrinkles, crow’s feet, crepey under-eye skin, sun damage, or the residual scars from a previous blepharoplasty, fractional resurfacing offers a tailored middle path. Understanding where it sits in the broader spectrum of laser technology—and how it compares to full CO2 laser resurfacing—helps patients set realistic expectations and choose the right approach for their skin and their tolerance for downtime.
Laser skin resurfacing exists on a spectrum defined by two questions: how much of the skin surface is treated, and whether the laser removes (ablates) tissue or heats it without vaporization. Understanding these two axes clarifies nearly every device on the market.
Ablative lasers vaporize the outer layers of skin. Fully ablative CO2 (10,600 nm) and erbium:YAG (2,940 nm) lasers remove the entire epidermis across the treatment area, producing the most powerful tightening and wrinkle reduction but requiring one to two weeks of intensive wound care and weeks to months of redness. Non-ablative lasers pass through the epidermis and deliver heat to the dermis without breaking the surface, stimulating collagen with almost no visible wound—but with correspondingly subtler results that require several sessions.
Fractional technology can be applied to either category. A fractional laser divides its beam into hundreds or thousands of tiny microthermal treatment zones, sparing the surrounding tissue. This creates a reservoir of healthy cells that migrate inward to heal each column rapidly.
The single greatest advantage of fractional technology is controllable downtime. By adjusting density and depth, Dr. Leibowitz can dial treatment intensity up toward CO2-like results or down toward a lunch-hour refresh. Learn more about the full range of laser treatments used in oculoplastic practice.
The fractional category includes a growing family of devices, each with a characteristic wavelength, ablation profile, and clinical niche. While brand names come and go, the underlying physics determines what each device can and cannot do around the eyes.
Fractional CO2 devices (Fraxel Re:pair, Lumenis ActiveFX and DeepFX, and various UltraPulse platforms) combine the deep collagen-stimulating power of the 10,600 nm CO2 wavelength with the reduced downtime of fractional delivery. ActiveFX treats more superficially for tone and fine texture, while DeepFX drives narrow columns deeper into the dermis for wrinkles and scars—the two are frequently combined in a single session (“TotalFX”). Fractional CO2 remains the most powerful fractional option and produces results closest to fully ablative treatment.
Erbium-based systems (fractional erbium:YAG devices at 2,940 nm and the Sciton Halo hybrid platform) offer excellent precision with slightly less residual thermal spread than CO2. The Sciton Halo notably combines an ablative and non-ablative wavelength in one pass, giving both surface renewal and deeper collagen effect with a favorable recovery profile that many patients find well-suited to the delicate periocular region.
Non-ablative fractional devices (Fraxel Restore 1550/1927 and Clear + Brilliant) heat the dermis through an intact epidermis. These are the mildest members of the family, ideal for early sun damage, pigment irregularity, and maintenance treatments. The 1927 nm thulium wavelength is particularly effective for superficial pigmentation and pre-cancerous actinic change, while Clear + Brilliant is marketed as an entry-level “preventive” treatment with minimal downtime.
| Device Type | Wavelength | Best For | Typical Downtime |
|---|---|---|---|
| Fractional CO2 (Re:pair, DeepFX) | 10,600 nm | Deeper lines, scars, laxity | 5–7 days |
| Fractional Erbium (Sciton Halo) | 1470 + 2940 nm | Tone, texture, moderate lines | 3–5 days |
| Non-ablative (Fraxel Restore) | 1550/1927 nm | Fine lines, pigment, sun damage | 1–3 days |
| Clear + Brilliant | 1440/1927 nm | Maintenance, early aging | 1–2 days |
The skin around the eyes is the thinnest on the body, which makes it both the first area to show aging and one of the most rewarding—and delicate—regions to treat. Fractional resurfacing is especially well matched to periocular concerns because its adjustable depth allows the surgeon to treat thin lower-lid skin safely while using more aggressive settings on the thicker crow’s-feet zone.
Fractional laser is one component of a broader skin rejuvenation strategy. For deeper structural laxity, energy-based tightening such as RF microneedling may complement or substitute for laser depending on skin type.
Recovery is where fractional resurfacing most clearly differentiates itself from fully ablative treatment. Because untreated skin surrounds each microthermal zone, re-epithelialization—the resurfacing of the skin barrier—happens in days rather than weeks.
After full CO2 laser resurfacing, patients typically face 7–14 days of open-wound care with oozing, crusting, and meticulous ointment application, followed by weeks to several months of pink or red skin that requires camouflage makeup. The tradeoff is a dramatic, often single-treatment result.
Fractional treatment substitutes multiple gentler sessions for one intense one. Expect the following general timeline, which varies by device intensity:
Important: “Less downtime” does not mean “no downtime.” Strict sun avoidance and daily broad-spectrum SPF are mandatory for weeks after any resurfacing to prevent post-inflammatory hyperpigmentation, which can be persistent around the eyes.
A patient’s Fitzpatrick skin type—a scale of skin pigmentation and sun response—is one of the most important factors in laser selection. Melanin absorbs laser energy, so darker skin types carry a higher risk of post-inflammatory hyperpigmentation (PIH) and, less commonly, hypopigmentation.
Fractional technology partially mitigates this risk because the surrounding untreated skin helps the treated zones heal without triggering as much pigment reaction as fully ablative treatment. Nevertheless, careful device selection matters:
Important: A history of cold sores (herpes simplex) requires antiviral prophylaxis before periocular resurfacing, as laser injury can trigger a widespread outbreak. Active infection, isotretinoin use within the prior 6–12 months, and a tendency toward keloid scarring are additional considerations Dr. Leibowitz will review.
One of the most common questions patients ask is whether fractional laser can be performed at the same time as eyelid surgery. The answer is a qualified yes—and the nuances matter for both safety and results.
Skin resurfacing and lower eyelid blepharoplasty address different problems: surgery removes or repositions excess skin and fat, while laser improves the quality of the skin that remains—its fine wrinkling, texture, and elasticity. Combining them can deliver a more complete rejuvenation than either alone.
However, when skin is being simultaneously undermined surgically and resurfaced with an ablative laser, blood supply to that skin can be compromised, raising the risk of delayed healing or lower-lid retraction. For this reason, many surgeons:
For patients weighing surgery against energy-based options, our comparison of non-surgical eye lift techniques explains where laser fits versus what only surgery can accomplish.
Honesty about outcomes is essential to patient satisfaction, and this is where fractional resurfacing must be positioned carefully against full CO2 treatment.
Fractional resurfacing produces gradual, cumulative improvement. A single non-ablative session yields a modest brightening and texture change; a series of three to five sessions builds meaningful improvement in fine lines, tone, and skin quality. Fractional CO2 delivers more per session and can approach—but not fully equal—the wrinkle reduction and tightening of fully ablative CO2. In head-to-head terms, fully ablative CO2 remains the gold standard for the deepest periocular wrinkles and the most significant skin tightening, at the cost of substantially longer recovery.
Reasonable expectations include:
Importantly, no laser corrects excess eyelid skin (dermatochalasis), herniated fat pads, or true lid laxity. Patients with those anatomic problems will be better served—or complemented—by upper eyelid blepharoplasty or a formal lower-lid procedure. A thorough consultation distinguishes skin-quality concerns (a laser problem) from structural concerns (a surgical problem).
Choosing between fractional and fully ablative resurfacing—and choosing the right device for your skin type—requires the judgment of a physician who understands both the laser physics and the delicate anatomy of the eyelids and orbit. An ASOPRS fellowship-trained oculoplastic surgeon is uniquely qualified to treat the periocular region safely, balancing cosmetic goals against the functional protection of the eye. If you are considering laser skin rejuvenation around your eyes, find a qualified oculoplastic surgeon near you to discuss which approach best fits your skin, your concerns, and your tolerance for downtime.
Your Surgeon
Steven Leibowitz, MD
Cosmetic and Reconstructive Surgery of Eyelids, Orbits, and Tear Ducts
🏅 ASOPRS Fellowship Trained
Schedule a consultation with Steven Leibowitz, MD to learn if this procedure is right for you.
